These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15583798)
1. Somatostatin receptor scintigraphy in metastatic breast cancer patients. Mezi S; Primi F; Orsi E; Capoccetti F; Scopinaro F; Schillaci O Oncol Rep; 2005 Jan; 13(1):31-5. PubMed ID: 15583798 [TBL] [Abstract][Full Text] [Related]
2. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873 [TBL] [Abstract][Full Text] [Related]
5. [The scintigraphy of somatostatin receptors in the carcinoid tumor]. Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma]. Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059 [TBL] [Abstract][Full Text] [Related]
7. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy in advanced renal cell carcinoma. Results of a phase II-trial of somatostatine analogue therapy in patients with advanced RCC. Freudenberg LS; Gauler T; Görges R; Bauer S; Stergar H; Antoch G; Bockisch A; Schütte J Nuklearmedizin; 2008; 47(3):127-31. PubMed ID: 18493693 [TBL] [Abstract][Full Text] [Related]
9. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management. Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189 [TBL] [Abstract][Full Text] [Related]
10. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361 [TBL] [Abstract][Full Text] [Related]
11. Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma. Friedberg JW; Van den Abbeele AD; Kehoe K; Singer S; Fletcher CD; Demetri GD Cancer; 1999 Oct; 86(8):1621-7. PubMed ID: 10526294 [TBL] [Abstract][Full Text] [Related]
12. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS. Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas. Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520 [TBL] [Abstract][Full Text] [Related]
14. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310 [TBL] [Abstract][Full Text] [Related]
15. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698 [TBL] [Abstract][Full Text] [Related]
16. Dynamic indium-111-pentetreotide scintigraphy in breast cancer. Bajc M; Ingvar C; Palmer J J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252 [TBL] [Abstract][Full Text] [Related]
17. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors. Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703 [TBL] [Abstract][Full Text] [Related]
18. Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. Leboulleux S; Dromain C; Vataire AL; Malka D; Aupérin A; Lumbroso J; Duvillard P; Elias D; Hartl DM; De Baere T; Guigay J; Schlumberger M; Ducreux M; Baudin E J Clin Endocrinol Metab; 2008 Aug; 93(8):3021-8. PubMed ID: 18522978 [TBL] [Abstract][Full Text] [Related]
19. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours. Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127 [TBL] [Abstract][Full Text] [Related]